CO [China Cord Blood] 6-K/A: (Original Filing)

[FORM 6-K/A (Amendment No. 1) For the month of December 2017 CHINA CORD BLOOD CORPORATION 48 th Floor, Bank of China Tower Form 20-F x o o o Yes o x EXPLANATORY NOTE 2 Results of Operations and Financial Condition Following this cover page are the unaudited condensed consolidated financial results fo]

By | 2017-12-10T07:15:45+00:00 December 6th, 2017|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K/A: FORM 6-K/A (Amendment No. 1) For the month

[FORM 6-K/A (Amendment No. 1) For the month of December 2017 CHINA CORD BLOOD CORPORATION 48 th Floor, Bank of China Tower Form 20-F x o o o Yes o x EXPLANATORY NOTE 2 Results of Operations and Financial Condition Following this cover page are the unaudited condensed consolidated financial results fo]

By | 2017-12-10T07:15:47+00:00 December 6th, 2017|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2018 2Q18 Added 23,647 New Subscribers 2Q18 Revenues Up 27.4% YOY to RMB234.6 Million ($35.3 Million) 2Q18 Operating Income Up 39.4% YOY to RMB76.3 Million ($11.5 Million) Conference Call to be Hel]

By | 2017-11-21T03:47:57+00:00 November 20th, 2017|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: China Cord Blood Corporation Reports Financial Results for

[China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2018 2Q18 Added 23,647 New Subscribers 2Q18 Revenues Up 27.4% YOY to RMB234.6 Million ($35.3 Million) 2Q18 Operating Income Up 39.4% YOY to RMB76.3 Million ($11.5 Million) Conference Call to be Hel]

By | 2017-11-21T03:48:01+00:00 November 20th, 2017|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC 13D/A: (Original Filing)

[54 Confidential Supplemental Agreement to Share Purchase Agreement In relation to China Cord Blood Corporation By and among Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (limited partnership) and Golden Meditech Stem Cells (BVI) Company Limited and Golden Meditech Holdings Limit]

By | 2017-11-14T15:30:46+00:00 November 14th, 2017|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC 13D/A: 54 Confidential Supplemental Agreement to Share Purchase Agreement

[54 Confidential Supplemental Agreement to Share Purchase Agreement In relation to China Cord Blood Corporation By and among Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (limited partnership) and Golden Meditech Stem Cells (BVI) Company Limited and Golden Meditech Holdings Limit]

By | 2017-11-14T15:30:50+00:00 November 14th, 2017|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: (Original Filing)

[CHINA CORD BLOOD CORPORATION (Incorporated in the Cayman Islands with limited liability) 48 th 1 Garden Road Central Hong Kong S.A.R. NOTICE OF ANNUAL GENERAL MEETING To the Shareholders of China Cord Blood Corporation: NOTICE IS HEREBY GIVEN that th To table the financial statements of the Company ]

By | 2017-11-01T02:07:59+00:00 October 31st, 2017|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: CHINA CORD BLOOD CORPORATION (Incorporated in the Cayman

[CHINA CORD BLOOD CORPORATION (Incorporated in the Cayman Islands with limited liability) 48 th 1 Garden Road Central Hong Kong S.A.R. NOTICE OF ANNUAL GENERAL MEETING To the Shareholders of China Cord Blood Corporation: NOTICE IS HEREBY GIVEN that th To table the financial statements of the Company ]

By | 2017-11-01T02:08:02+00:00 October 31st, 2017|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] 20-F: (Original Filing)

[FORM 20-F o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: China Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albert Chen +852 3605 81]

By | 2017-07-26T02:19:50+00:00 July 25th, 2017|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] 20-F: FORM 20-F o OR x OR o For

[FORM 20-F o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: China Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albert Chen +852 3605 81]

By | 2017-07-26T02:20:18+00:00 July 25th, 2017|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar